Marcus Rodriguez, MSc

Marcus Rodriguez is the Biotech Industry Analyst at BioAge Insider, covering funding trends, M&A activity, and market dynamics in the longevity and biotech sectors. He brings a unique perspective combining scientific understanding with financial analysis. Marcus previously worked as a healthcare analyst at Goldman Sachs and later at a longevity-focused venture capital firm, where he evaluated over 200 biotech startups. He holds an MSc in Health Economics from the London School of Economics and a BS in Biology from Duke University. His analysis has been featured in Endpoints News, BioCentury, and the Longevity Summit Dublin. Marcus is particularly interested in the translation of longevity research into viable commercial therapies.